| [1] |
李双喜, 李娟, 赵丽芳. Framingham风险评估对慢性肾脏病患者心血管疾病患病风险预测及其危险因素分析[J]. 上海医学, 2019, 42(1): 8-10.
|
| [2] |
马丽媛, 吴亚哲, 陈伟伟. 《中国心血管病报告2018》要点介绍[J]. 中华高血压杂志, 2019, 27(8): 712-716.
|
| [3] |
唐健雄, 华蕾, 张逖, 等. 成人腹股沟疝患病情况的多中心研究[J]. 外科理论与实践, 2002, (6): 421-422.
|
| [4] |
Pierides G, Mittila K, Vironen J, et al. Quality of life change in elderly patients undergoing open inguinal hernia repair[J]. Hernia, 2013, 17(6): 729-736.
|
| [5] |
张繁疆, 曾环洪, 蓝锦文, 等. 前入路腹膜前间隙无张力疝修补术治疗成人腹股沟疝32例临床分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2011, 5(3): 320-324.
|
| [6] |
李航宇, 顾岩, 王明刚, 等. 老年腹股沟疝诊断和治疗中国专家共识(2019版)[J]. 中国实用外科杂志, 2019, 39(8): 782-787.
|
| [7] |
Kearon C, Hirsh G. Management of anticoagulation before and after elective surgery[J]. N Engl J Med, 1997, 336(21): 1506-1511.
|
| [8] |
刘凤林, 张太平. 中国普通外科围手术期血栓预防与管理指南[J]. 中国实用外科杂志, 2016, 36(5): 469-474.
|
| [9] |
Dumlu E G, Kılınç İ. Factors associated with bleeding complications in hernia repair of warfarin users[J]. Rev Assoc Med Bras(1992), 2021, 67(11): 1605-1609.
|
| [10] |
王学虎, 赵渝. 腹股沟疝修补术后出血及抗栓药物影响的临床分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2020, 14(3): 224-227.
|
| [11] |
黄永刚, 叶静, 张方捷, 等. 腹股沟疝修补术后腹膜前间隙出血危险因素分析及急诊处理[J/OL]. 中华危重症医学杂志(电子版), 2017, 10(5): 328-333.
|
| [12] |
Stucky C-CH, Garvey EM, Johnson DJ, et al. Challenging a surgical dictum: results from a 10-year experience on the safety of open inguinal herniorrhaphy in patients on chronic warfarin therapy[J]. Hernia, 2015, 19(1): 83-87.
|
| [13] |
Kazuhito M, Keiichi F, Hideki A, et al. Postoperative bleeding complications after endoscopic inguinal hernia repair in patients receiving anticoagulation agents, antiplatelet agents, or both[J]. Asian J Endosc Surg, 2019, 13(1): 71-76.
|
| [14] |
Hada G, Zhang S, Song Y, et al. Safety of Inguinal Hernia Repair in the Elderly with Perioperative Continuation of Antithrombotic Therapy[J]. Surg Endosc, 2021, 37(4): 315-322.
|
| [15] |
Chu EW, Chernoguz A, Divino CM. The evaluation of clopidogrel use in perioperative general surgery patients: a prospective randomized controlled trial[J]. Am J Surg, 2016, 211(6): 1019-1025.
|
| [16] |
张森, Hada G, 简福顺, 等. 血栓药物对局部麻醉腹股沟疝无张力修补患者的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2020, 14(5): 476-480.
|
| [17] |
Hill DA, Sleiman M, Castellano MR, et al. Is the Perioperative Continuation of Antiplatelet Therapy Safe for Elective Hernia Surgery?[J]. Am Surg, 2019, 85(3): 303-305.
|
| [18] |
Li J, Wang M, Cheng T, et al. The safe and risk assessment of perioperative antiplatelet and anticoagulation therapy in inguinal hernia repair, a systematic review[J]. Surg Endosc, 2019, 33(10): 3165-3176.
|
| [19] |
刘宇萌, 石文征, 赵力, 等. 腹腔镜经腹腹膜前腹股沟疝修补术术前低分子肝素抗凝治疗的安全性[J]. 中国研究型医院, 2022, 9(4): 68-70.
|
| [20] |
Masaki W, Mitsuyoshi T, Yozo S, et al. Single-incision totally extraperitoneal inguinal hernia repair is feasible and safe in patients on antithrombotic therapy: A single-center experience of 92 procedures[J]. Asian J Endosc Surg, 2017, 10(3): 301-307.
|
| [21] |
张捷, 刘骅, 沈志勇, 等. 围手术期低分子肝素代替抗凝药物对腹股沟疝患者的安全性评估[J]. 中国普外基础与临床杂志, 2014, 21(11): 1417-1420.
|
| [22] |
叶少波, 陈育鸿, 詹楚文. 低分子肝素在腹股沟疝无张力修补术围手术期的安全性评估[J]. 北方药学, 2016, 13(5): 16-17.
|
| [23] |
张明, 朱信强, 丁闯, 等. 腹股沟疝合并心房颤动患者的围手术期抗凝治疗[J]. 医学理论与实践, 2016, 29(23): 3181-3183.
|
| [24] |
朱鸣雷, 黄宇光, 刘晓红, 等. 老年患者围手术期管理北京协和医院专家共识[J]. 协和医学杂志, 2018, 9(1): 36-41.
|
| [25] |
Bay-Nielsen M, Kehlet H. Anaesthesia and post-operative morbidity after elective groin hernia repair: a nation-wide study[J]. Acta Anaesthesiol Scand, 2008, 52(2): 169-174.
|
| [26] |
吴金成, 张思宇, 黄小蓉. 4种成人腹股沟疝术式术后复发的临床分析[J]. 中国卫生标准管理, 2018, 9(17): 68-71.
|
| [27] |
Ho CH, Wu CC, Wu CC, et al., et al. Laparoscopic total extraperitoneal inguinal hernia repair is safe and feasible in patients with continuation of antithrombotics[J]. J Minim Access Surg, 2019, 15(4): 299-304.
|
| [28] |
Wakasugi M, Akamatsu H, Yoshidome K, et al. Totally extraperitoneal inguinal hernia repair in patients on antithrombotic therapy: a retrospective analysis[J]. Surgery Today, 2013, 43(8): 942-945.
|
| [29] |
邓芝徽, 邢壮杰, 赵晖, 等. 腹腔镜腹股沟疝修补术患者术后出血及二次手术相关因素分析[J]. 现代生物医学进展, 2016, 16(9): 1691-1694.
|
| [30] |
Balch JA, Neal D, Crippen C, et al. Safety of laparoscopic inguinal hernia repair in the setting of antithrombotic therapy[J]. Surg Endosc, 2022, 36(12): 9011-9018.
|
| [31] |
冯勇, 杨立东, 赵海涛. 普外治疗心血管患者时麻醉方法的选择[J]. 大家健康(学术版), 2014, 8(7): 110.
|
| [32] |
马虹. 合并心血管疾病普通外科病人麻醉方法选择[J]. 中国实用外科杂志, 2008, 28(2): 109-112.
|
| [33] |
王明刚, 李航宇, 张光永, 等. 我国成年人腹股沟疝围手术期静脉血栓栓塞症发生率和相关因素现状调查(CHAT-1)[J]. 中国实用外科杂志, 2019, 39(8): 815-820.
|
| [34] |
Tomasz C, Piotr Z, Mateusz P, et al. Safe and uncomplicated inguinal hernia surgery in the elderly-message from anesthesiologists to general surgeons[J]. Polski przeglad chirurgiczny, 2017, 89(2): 5-10.
|
| [35] |
HerniaSurge Group. International guidelines for groin hernia management[J]. Hernia, 2018, 22(1): 1-165.
|
| [36] |
刘业星, 张冬辉, 庄哲宏, 等. 腹腔镜完全腹膜外疝修补术和平片修补术治疗长期使用抗凝药物的腹股沟疝患者的对比研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2019, 13(1): 47-50.
|
| [37] |
韦琴, 陈璐, 朱帅, 等. 中高血栓风险患者李金斯坦手术围术期不停用抗血栓药物的安全性分析[J]. 中国普通外科杂志, 2022, 31(4): 490-496.
|
| [38] |
余建伟, 代聪聪, 吴立胜. 长期口服华法林腹股沟疝患者不停药行Lichtenstein手术治疗的安全性分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2020, 14(4): 408-411.
|
| [39] |
唐维寅, 唐健雄. 老年腹股沟疝的外科治疗历史及现状[J]. 老年医学与保健, 2016, 22(2): 130-131.
|
| [40] |
王春玲, 赖杰. 老年心血管疾病的抗凝治疗进展及策略[J]. 中国研究型医院, 2020, 7(1): 91-96, 219-225.
|
| [41] |
White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures[J]. Thromb Haemost, 2003, 90(3): 446-455.
|
| [42] |
Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism[J]. J Thromb Thrombolysis, 2016, 41(1): 3-14.
|
| [43] |
杨慧琪. 老年腹股沟疝病人围手术期出凝血管理进展[J]. 中国实用外科杂志, 2018, 38(8): 942-944.
|
| [44] |
李建军, 郭江涛, 李红雨. 腹股沟疝患者术后下肢深静脉血栓形成的风险评估及治疗对策[J]. 血栓与止血学, 2022, 28(2): 292-293.
|